Efficacy of chemotherapy in patients with HR+/HER2–Invasive lobular breast cancer

Efficacy of chemotherapy in patients with HR+/HER2–Invasive lobular breast cancer

Introduction: : Invasive Lobular Breast Cancer (ILC) harbors unique clinicopathologic features. Data on optimal treatment modalities focusing on ILC remain scarce. We aim to investigate the benefit of chemotherapy in early-stage hormone receptor-positive (HR+) and human epidermal growth factor recep...

Full description

Bibliographic Details
Main Authors: Marita Yaghi, Nadeem Bilani, Barbara Dominguez, Maroun Bou Zerdan, Hong Li, Diana Saravia, Elizabeth Stone, Zeina Nahleh
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Breast neoplasms, drug therapy
Breast neoplasms, genetics
Breast Neoplasms, pathology
Genomics, methods
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222001575

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222001575

Similar Items